AltraBio is a provider of Research and Development (R&D) services in analysis and interpretation of biomedical data in both preclinical and clinical development. Particularly focused on OMICS (e.g., genomics, transcriptomics, proteomics) and Flow/Mass cytometry technologies, the goal of AltraBio is to unlock the value captured in large scale datasets generated in life science experimental studies (Brochure). M
The analysis and interpretation team is made of highly skilled professionals with transversal, double expertise in medicine, biology and bio-informatics/mathematics. We are not only able to provide quick and efficient statistical analysis, but also to understand the end customers' own questioning and help redesign the research studies.
Julien Nourikyan, Business Developer, will participate to the "Vaccin Zika France" meeting co-organized by CoReVac and REACTing in Paris on September, 16th 2016. This event will be focused on the f...Read More
Julien Nourikyan, Business Developer, will attend a workshop organized by the ARDI Rhône-Alpes about the « industrial and intellectual property in european projects » in Lyon on September, 22nd 201...Read More
Our international collaborative work named "CD1d-restricted peripheral T cell lymphoma in mice and humans." was published in the Journal of Experimental Medicine. https://www.ncbi.nlm.nih.gov/pubme...Read More
AltraBio is located on the 3rd floor of the building at 30 rue Pré-Gaudry in the 7th arrondissement of Lyon (Gerland district).
Metro B - Place Jean Jaurès. Map of TCL, the Lyon city public transport system.